T. Rowe Price Group, Inc.

Executive Summary

BUY, Medium conviction. Rated BUY, Medium conviction. The stock sits at $121.68, just 0.3% below its 52-week high, yet still trades at only 12.77x FY2025 EPS of $9.26 versus a 24.8x peer average, despite 33.0% operating margin, 28.2% net margin, and a near-debt-free balance sheet. The key debate is whether persistent equity outflows outweigh fee pressure and growth adjacencies, but the current valuation already discounts too much structural decline relative to the company's improving product mix, capital return, and operating discipline.

Investment Thesis

The market is still valuing TROW like a high-quality asset manager with a structurally broken business. The first half of that description is true, the second is too harsh. TROW posted FY2025 revenue of $7.3B, EPS of $9.26, and a 33.0% operating margin, while carrying only $0.4B of debt and Debt/EBITDA of 0.15. Yet the stock trades at just 12.77x earnings against a 24.8x peer average. That discount would make sense if earnings were rolling over hard and the balance sheet were being used to patch holes. Neither is happening.

The case depends on three things. First, management only needs modest organic improvement to produce decent EPS growth because expenses are being controlled tightly. FY2026 adjusted operating expenses ex carried interest are guided to +3% to +6% on a $4.6B base, and Q1 2026 still delivered $2.52 of adjusted EPS, up 13% YoY, despite $13.7B of net outflows. Second, the mix is changing in directions that deserve higher confidence than the stock implies. ETFs are no longer a rounding error, with the platform now above $25B AUM, $2.8B of Q1 net flows, and 32 products. Alternatives are also becoming more relevant, with OHA dry powder above $30B and a new CLO capability broadening the offering. Third, capital return is meaningful because the balance sheet is so clean. TROW produced $0.9B of FCF, spent just $0.1B on capex, repurchased $340M of stock in Q1, and raised the dividend to $1.30/share.

What the market is correctly worried about is flow quality. Equity and mutual fund outflows are still persistent, and fee rate compression from 41.6 bps in 2024 Q2 to 38.4 bps ex performance fees in 2026 Q1 is not noise. This is why conviction is Medium, not High. The business is adapting, not escaping industry gravity.

At $121.68, the stock is no longer cheap on sentiment because it sits near its 52-week high, but it is still cheap on earnings power. If TROW can keep margins stable, prevent fee erosion from accelerating, and keep ETFs, target date, SMAs, and alternatives growing, the current valuation is too low by a wide margin.

Key Metrics

Financial Strength

The financial profile is one of the cleanest in the group. TROW combines 33.0% operating margin and 28.2% net margin with almost no leverage, which materially lowers downside risk if markets soften or flows remain negative. Cash generation remains solid at $0.9B of FCF despite active-management pressure, and low capex needs keep conversion high. The main financial watchpoint is not solvency or liquidity, it is mix-driven fee compression, because a lower-fee asset base can slowly chip away at margin quality even if expenses are tightly managed.

Competitive Position

TROW's moat rests on brand, retirement-plan distribution, institutional relationships, and long-dated trust with advisors and asset owners, not on switching costs alone. That moat is narrower in active U.S. equity, where performance and pricing pressure are intense, but it is more durable in retirement, multi-asset, fixed income, and alternatives where advice, fiduciary trust, and platform access matter. The moat should remain investable over the next 3 to 5 years if product mix keeps shifting toward ETFs, SMAs, and private markets fast enough to offset legacy mutual-fund erosion.

Management & Guidance

Current guidance is centered on cost discipline and strategic launches rather than a bold flow inflection promise. CFO Jen Dardis said, "We continue to expect 2026 adjusted operating expenses, excluding carried interest expense, to be up 3% to 6% over 2025." She also said, "While it's still too early to narrow our guidance, our expense forecast, which includes our investment in strategic priorities and market-driven expenses, remains comfortably within this range even with the market volatility experienced year-to-date." That is credible because recent earnings delivery has been decent, with 5 beats in the last 8 quarters, and because Q1 2026 showed higher earnings despite heavy outflows. The weak point is flows, where management has not yet proven it can sustainably return the firm to positive net organic growth.

Segment Analysis

• Total company ($7.3B revenue in FY2025): Revenue grew 4.6% YoY, supported by higher average AUM despite ongoing active-equity pressure.
• Retirement / Target Date (Not disclosed): Remains a key franchise, with +$4.9B net inflows in Q1 2026 and $10.5B of inflows in 1H24.
• ETFs (>$25B AUM): AUM scaled from $5.3B in 2024 Q2, with $2.8B of Q1 2026 net flows and 32 products now in market.
• Alternatives / OHA (>$30B dry powder): Institutional demand remains strong, and the first TRP-managed CLO closed in early April, adding floating-rate capability.
• SMAs (Not disclosed): Generated $962M net flows in Q1 2026, showing traction in strategic growth vehicles.

Capital Allocation

Capital allocation is disciplined and shareholder-friendly. TROW generated $0.9B of FCF on only $0.1B of capex, returned $0.3B via buybacks and $0.3B via dividends in the deep-dive period, and then stepped up to $340M of buybacks in Q1 2026 while raising the dividend to $1.30/share. With only $0.4B of debt and Debt/EBITDA of 0.15, management has room to keep repurchasing stock and fund product expansion without stressing the balance sheet.

Management Execution & Track Record

Execution has been mixed but credible. On the 2024 Q2 call, management said, "We continue to be on track to substantially reduce net outflows this year." and warned that 2H24 outflows would run above the $3.7B Q2 pace while still below FY23, which fit the still-challenged flow profile that persisted into 2025 and 2026. They also targeted a return to positive flows at some point in calendar 2025, but by 2026 Q1 the company still posted $13.7B net outflows, so that specific aspiration was missed. On expenses, the company looks stronger: FY24 expense guidance was +6% to +8% over a $4.19B base, and by 2026 Q1 management had reset FY26 expense growth to +3% to +6% on a $4.6B FY2025 base while still growing EPS, showing real cost discipline. The ETF strategy has clearly overdelivered versus the 2024 base, with ETF AUM rising from $5.3B to more than $25B and the lineup expanding to 32 products. The earnings record also supports moderate credibility, with 5 beats and 3 misses over the last eight quarters, including a +8.2% beat in April 2026 and two prior beats above 10%.

Positioning & Flows

Ownership is concentrated, with the top three institutions at 65.9%, which tends to dampen float turnover but can amplify reaction if flows or guidance disappoint. Short interest is high at 12.73%, or 26.7M shares, with 12.5 days-to-cover, so the setup can squeeze on a strong flow or margin report. Options positioning is in a negative gamma regime with zero-gamma at $127.1, about 4.18% above spot, which points to potentially sharper post-earnings moves rather than a stable drift.

Bull Case

• The balance sheet is unusually strong for the sector, with Debt/Equity 0.04, Debt/EBITDA 0.15, current ratio 7.43, and only $0.4B of total debt, which supports both defense and capital return.
• Management is protecting earnings despite outflows: FY2026 adjusted operating expenses ex carried interest are guided to only +3% to +6% on a $4.6B FY2025 base, and Q1 2026 adjusted EPS still rose 13% YoY to $2.52.
• Newer channels are scaling from a small base to meaningful size. ETF AUM grew from $5.3B in 2024 Q2 to more than $25B by 2026 Q1, with the lineup now at 32 ETFs and Europe launch plans in development.
• Capital return has accelerated, with $340M of Q1 buybacks and the dividend raised to $1.30/share, backed by $0.9B of FCF and limited leverage.

Bear Case

• Organic growth is still weak. Q1 2026 ended with $1.71T AUM but also $13.7B net outflows, with equities and mutual funds still leaking assets.
• Fee compression is real and ongoing. Fee rate fell to 38.4 bps ex performance fees in Q1 2026 from 41.6 bps in 2024 Q2, showing mix shift toward lower-fee vehicles and products.
• The stock is no longer washed out. At $121.68, shares are 18.9% above the 200-day average and only 0.3% below the 52-week high, so a near-term beat may already be partly priced ahead of the July 31, 2026 earnings report.
• Market sentiment remains the weakest quality sub-score at 38, and short interest is elevated at 12.73% with 12.5 days-to-cover, reflecting a credible bear case around secular active-management outflows.

Valuation & Price Target

Engine price target $181.68 (+49.3% vs current), Medium confidence.

• P/E Multiple: $245.16 (27% weight)
• P/S Multiple: $164.55 (20% weight)
• Quality-adjusted: $153.49 (20% weight)
• DCF: $124.6 (14% weight)

The rating aligns with the quant baseline of BUY, and the core reason is straightforward: the stock trades at 12.77x earnings with a 71/100 quality score, 35/100 risk score, and a fortress balance sheet, while the engine's blended target is $181.68. The main reason not to raise conviction to High is that the best bearish argument is real, not cosmetic: $13.7B of Q1 net outflows and a fee-rate decline to 38.4 bps show the legacy business is still shrinking organically. Sell-side consensus sits at 0 buy / 5 hold / 3 sell, but that looks backward-looking and overly anchored to active-equity outflows. The valuation, margins, and capital return profile justify staying with the quant BUY, even if the path is not clean.

Risk Assessment

Risk score 35/100 (Low). The biggest risk is that equity and mutual fund outflows persist at a pace closer to Q1's $13.7B quarterly net outflow, which would keep fee rates under pressure and block any sustained earnings re-rating.

The Bottom Line

Rated BUY, Medium conviction. TROW offers an unusual mix of strong margins, minimal leverage, solid cash generation, and low valuation, even after a sharp move to near its 52-week high. The stock is not a clean secular-growth story, but it does not need to be at 12.77x earnings to work. The next report needs to show that fee pressure and outflows are not worsening faster than ETFs, retirement, SMAs, and alternatives are growing. A shift to HOLD would require evidence that quarterly outflows remain near $13.7B and fee rate deterioration accelerates meaningfully below 38.4 bps.